---
title: "Medicus Pharma (MDCX.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/MDCX.US/norm.md"
symbol: "MDCX.US"
name: "Medicus Pharma"
parent: "https://longbridge.com/en/quote/MDCX.US.md"
datetime: "2026-05-21T23:18:32.961Z"
locales:
  - [en](https://longbridge.com/en/quote/MDCX.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/MDCX.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/MDCX.US/norm.md)
---

# Medicus Pharma (MDCX.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.3100 | -0.8100 | -1.12 | -0.4324 | -0.4168 |
| ROE | -5747.88% | 12329.00% | -7161.86% | -915.61% | -772.76% |
| Revenue | - | - | - | - | - |
| Net income | -9.04M | -15.07M | -20.94M | -6.18M | -5.10M |
| Operating income | -8.60M | -7.79M | -6.71M | -6.02M | -5.13M |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 7.43M | 10.06M | 9.98M | 11.93M | 5.66M |
| Leverage | 5.20 | 269.66 | -12.40 | 3.67 | 2.63 |
| BVPS | 0.0332 | -0.0027 | -0.0434 | 0.2039 | 0.1601 |
| Turnover | - | - | - | - | - |
| Cash & STI | 6.37M | 8.71M | 8.66M | 9.67M | 3.98M |
| Inv & Rec | - | - | - | - | - |
| LT assets | 144331.00 | 170733.00 | 196249.00 | 220999.00 | 245091.00 |
| Net debt | -3.83M | -3.23M | -1.61M | -4.70M | -3.69M |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -8.97M | -6.61M | -6.76M | -5.47M | -3.94M |
| Investing CF | - | 0.0000 | -4.62M | - | - |
| Financing CF | 6.83M | 6.65M | 10.37M | 11.16M | 3.76M |
| Free CF | -6.19M | -3.69M | -3.12M | -3.36M | -1.81M |
| OCF coverage | -281.63% | -376.93% | -119.87% | - | - |
| Repaid & issued | - | 0.0000 | 7.37M | 4.50M | - |
| CapEx | - | - | - | - | - |